Teva Pharmaceuticals, a global pharmaceutical company, signed a strategic partnership and licensing agreement on Tuesday with NeuroGen, a China-based biopharmaceutical company, to advance the ...

Lupron Depot (leuprolide acetate) is a brand-name injection prescribed for prostate cancer and other hormone-related conditions. Lupron Depot’s side effects may vary depending on the dosage and the ...

On April 16, 2026, the U.S. Court of Appeals for the Federal Circuit reversed the district court’s judgment as a matter of law ...

Eylea (aflibercept) injections can cause both mild and serious side effects, though serious side effects are rare according to clinical trials. Mild side effects include eye floaters, redness, and ...

Peptide injections have become the wellness world’s biggest health hack. Proponents believe these shots can build muscle, rejuvenate skin, heal injuries, and otherwise promote vitality and longevity.

When you use links on our website, we may earn a fee. Terms Apply. Choose from the top auto loans to ensure you're getting the best deal for your new or used vehicle. Choose from the top auto loans to ...

(Yicai) April 22 – Teva Pharmaceutical Industries has teamed up with NeuroGen Pharma to jointly promote the wide availability of migraine treatment AJOVY in China. NeuroGen Pharma will acquire the ...

Israeli drugmaker Teva Pharmaceutical Industries (NYSE: TEVA) has regained the upper hand in its long-running migraine patent dispute with US pharma major Eli Lilly (NYSE: LLY), after a federal ...

Following a quiet stretch, the legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva gaining favor on appeal after a 2023 reversal of its prior patent win. The ...

Patient-reported outcomes reflected strong acceptance, with a median satisfaction score of 8.9 out of 10 on the Self-Injection Assessment Questionnaire. The zilucoplan (Zilbrysq ®) auto-injector ...

WASHINGTON, April 16 (Reuters) - A U.S. appeals court on Thursday revived a patent lawsuit that Teva Pharmaceutical (TEVA.TA), opens new tab brought against Eli Lilly (LLY.N), opens new tab over the ...

The Federal Circuit reversed a ruling that had wiped out Teva Pharmaceuticals International GmbH’s $177 million Ajovy patent verdict based on an infringing Eli Lilly and Co. headache medicine. A ...